Alan I. Kirshner Sells 100 Shares of Markel Co. (MKL) Stock

Markel Co. (NYSE:MKL) insider Alan I. Kirshner sold 100 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $1,133.50, for a total transaction of $113,350.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Shares of Markel Co. (NYSE MKL) traded up $3.41 during midday trading on Wednesday, hitting $1,119.72. 30,368 shares of the company’s stock traded hands, compared to its average volume of 31,300. The stock has a market cap of $15,560.00, a price-to-earnings ratio of 249.38 and a beta of 1.04. Markel Co. has a 52 week low of $612.00 and a 52 week high of $1,157.30. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 0.28.

Several hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Markel by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 1,129,189 shares of the insurance provider’s stock worth $1,101,931,000 after purchasing an additional 28,104 shares in the last quarter. BlackRock Inc. boosted its position in shares of Markel by 0.4% during the 2nd quarter. BlackRock Inc. now owns 836,138 shares of the insurance provider’s stock worth $815,955,000 after purchasing an additional 3,590 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Markel by 0.9% during the 3rd quarter. Principal Financial Group Inc. now owns 665,259 shares of the insurance provider’s stock worth $710,484,000 after purchasing an additional 6,092 shares in the last quarter. Atlanta Capital Management Co. L L C boosted its position in shares of Markel by 0.6% during the 3rd quarter. Atlanta Capital Management Co. L L C now owns 567,924 shares of the insurance provider’s stock worth $606,532,000 after purchasing an additional 3,264 shares in the last quarter. Finally, Baillie Gifford & Co. boosted its position in shares of Markel by 0.6% during the 2nd quarter. Baillie Gifford & Co. now owns 560,203 shares of the insurance provider’s stock worth $546,680,000 after purchasing an additional 3,147 shares in the last quarter. Institutional investors own 76.79% of the company’s stock.

Several brokerages have commented on MKL. Zacks Investment Research lowered shares of Markel from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Boenning Scattergood restated a “buy” rating on shares of Markel in a research report on Thursday, October 26th. Royal Bank of Canada restated a “hold” rating and set a $1,050.00 target price on shares of Markel in a research report on Tuesday, October 3rd. Finally, SunTrust Banks restated a “hold” rating and set a $1,100.00 target price on shares of Markel in a research report on Friday, October 27th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $1,066.67.

TRADEMARK VIOLATION WARNING: “Alan I. Kirshner Sells 100 Shares of Markel Co. (MKL) Stock” was first reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/03/alan-i-kirshner-sells-100-shares-of-markel-co-mkl-stock.html.

Markel Company Profile

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Insider Buying and Selling by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply